Survival analysis of breast cancer patients with different treatments: a multicentric clinicopathological study
Malik, S.S.; Baig, M.; Khan, M.B.; Masood, N.
JPMA. Journal of the Pakistan Medical Association 69(7): 976-980
2019
ISSN/ISBN: 0030-9982 PMID: 31308566 Document Number: 698002
To explore and better understand clinic pathological details of breast cancer patients and analyse their survival rate among different treatment groups. The prospective cohort, multi-centric study was conducted from September, 2014, to February, 2018, at five hospitals in Rawalpindi and Islamabad, Pakistan, and comprised histo-pathologically confirmed breast cancer cases. Patient characteristics and medical history were collected using a detailed questionnaire. All the subjects were followed up, and information regarding their current health and treatment status was collected. Data was analysed using SPSS 24. There were 347 subjects with a mean age of 44.3±12.2 years and body mass index of 27.9±4.0 kg/m2. Younger age, increased body mass index, consanguinity and family history were major contributing factors in breast cancer development (p<0.05). Overall, 267(77%) had invasive ductal carcinoma and Grade II tumour 234(67%) was more frequent. A total of 221(64%) cases had positive lymph nodes and 97(28%) had metastasis to different body organs. Overall survival analysis showed statistically significant role (p<0.0001) of all treatment options. Combination of different treatments can provide more promising health outcomes in breast cancer cases.